Medicenna Therapeutics Corp. (MDNA) Social Stream



Medicenna Therapeutics Corp. (MDNA): $0.16

0.02 (-13.16%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add MDNA to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#167 of 381

in industry

MEDICENNA THERAPEUTICS CORP (MDNA) Price Targets From Analysts

Use the tables below to see what analysts covering MEDICENNA THERAPEUTICS CORP think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-16 4 $12 $7 $10.018 $0.181 5434.81%
2022-02-10 5 $12 $7 $9.685 $0.181 5250.83%
2022-04-12 5 $12 $7 $9.671 $0.181 5243.09%
2022-06-03 5 $12 $4 $9.171 $0.181 4966.85%
2022-07-28 5 $11 $4 $7.985 $0.181 4311.6%
2022-08-15 5 $11 $4 $7.651 $0.181 4127.07%
2022-09-29 5 $10.14 $4 $7.151 $0.181 3850.83%
2022-11-06 4 $9 $4 $6.4 $0.181 3435.91%
2022-11-16 3 $9 $2.5 $6.1 $0.181 3270.17%
2023-04-19 4 $9 $2.5 $6.1 $0.181 3270.17%
2023-07-31 4 $9 $2.5 $6.625 $0.181 3560.22%
2023-08-10 4 $8 $2.5 $5.875 $0.181 3145.86%
2023-08-15 3 $7 $2.5 $5.166 $0.181 2754.14%

The Trend in the Analyst Price Target


MDNA's average price target has moved down $1.98 over the prior 51 weeks.

Over the past 40 weeks, MDNA's average upside potential has been 1,051.07%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-08 4 9 2.5 6.100 0.643 848.68%
2023-03-30 4 9 2.5 6.100 0.610 900%
2023-04-19 4 9 2.5 6.625 0.619 970.27%
2023-08-10 4 8 2.5 5.875 0.400 1368.75%
2023-08-15 3 7 2.5 4.625 0.409 1030.81%

MDNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 26 weeks, MDNA's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, MEDICENNA THERAPEUTICS CORP's upside potential (average analyst target price relative to current price) is greater than 1588.89% of them.
  • MDNA has a greater average analyst price target than 115.08% of all US stocks.
  • MEDICENNA THERAPEUTICS CORP's number of analysts covering the stock is higher than 1289.61% of stocks in the micro market cap category.
  • MEDICENNA THERAPEUTICS CORP's variance in analysts' estimates is lower than -1177.26% of stocks in the micro market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MEDICENNA THERAPEUTICS CORP are REVB, VIRI, and BPTS.

Is MDNA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!